Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor
US7183411B2 · kind B2 · utility
3Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2003 |
| Grant date | Feb 27, 2007 |
| Priority date | — |
| Expiry date | Oct 17, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to naphthol, quinoline and isoquinoline-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.